ARS PHARMACEUTICALS INC
SPRY · NASDAQ
更新於 2026-10-15 08:40:05
$3.93-2.96%
- 今日最高
- $4.09
- 今日最低
- $3.88
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $4.01
- 昨天收盤價
- $3.93
- 成交量
- 1.72M
- 市值
- $390.82M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-2.17
昨天價格區間
$3.88$4.09
52週價格區間
$3.98$13.15
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 11682 EL CAMINO REAL, SAN DIEGO, CA, UNITED STATES, 92130
- 國家
- 美國
- 上市日期
- 2020-12-04
- 財年截止
- 十二月
- 流通股數
- 99.3M
- CIK
- 0001671858
- 官方網址
- ars-pharma.com
ARS Pharmaceuticals, Inc. 研發 ARS-1，這是一種新型鼻內腎上腺素氣霧劑，採用吸收技術，適用於可能對食物、藥物及昆蟲叮咬產生嚴重過敏反應的患者及其家人。公司總部位於加州聖地牙哥。
財務指標
營業收入
2026-06-30
$33.65M
2026-03-31
$22.68M
2025-12-31
$28.08M
2025-09-30
$32.5M
營業支出
2026-06-30
$82.27M
2026-03-31
$76.54M
2025-12-31
$66.35M
2025-09-30
$77.5M
淨利潤
2026-06-30
-$62.33M
2026-03-31
-$60.61M
2025-12-31
-$41.32M
2025-09-30
-$51.15M
淨利潤率
2026-06-30
-185.21%
2026-03-31
-267.26%
2025-12-31
-147.12%
2025-09-30
-157.38%
每股收益
2026-06-30
$-0.63
2026-03-31
$-0.61
2025-12-31
$-0.42
2025-09-30
$-0.52
息稅折舊攤銷前利潤
2026-06-30
-$59.44M
2026-03-31
-$57.78M
2025-12-31
-$40.98M
2025-09-30
-$48.79M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
0.19%
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $33.65M | $22.68M | $28.08M | $32.5M |
| 營業支出 | $82.27M | $76.54M | $66.35M | $77.5M |
| 淨利潤 | -$62.33M | -$60.61M | -$41.32M | -$51.15M |
| 淨利潤率 | -185.21% | -267.26% | -147.12% | -157.38% |
| 每股收益 | $-0.63 | $-0.61 | $-0.42 | $-0.52 |
| 息稅折舊攤銷前利潤 | -$59.44M | -$57.78M | -$40.98M | -$48.79M |
| 有效稅率 | -- | -- | 0.19% | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。